No Data
No Data
Cachet Pharmaceutical (002462.SZ): Xu Xi was elected as Director.
On December 30, Geloonghui reported that Cachet Pharmaceutical (002462.SZ) announced that on December 30, 2024, the company held its third extraordinary Shareholder meeting of 2024, where the proposal on the election of a non-independent director was reviewed and approved, with Mr. Xu Xi officially becoming a non-independent director of the company's seventh Board of Directors. On the same day, the company held the fourteenth extraordinary meeting of the seventh Board of Directors, where the proposal on the election of the company's chairman was reviewed and approved, electing Mr. Xu Xi as the chairman of the company. According to the provisions of the Articles of Association, Mr. Xu Xi also serves as the legal representative of the company, with a term starting from the date of the Board review until the end of this Board.
Jiashitang: Report for the third quarter of 2024
Kashitang: 2024 Semi-Annual Report
Jiashitang: Summary of the 2024 Semi-Annual Report
Express News | Cachet pharmaceutical: The net income for the first half of the year was 0.168 billion yuan, a year-on-year increase of 8.19%.
Cachet Pharmaceutical (002462.SZ): net income of 0.168 billion yuan in the first half of the year, a year-on-year increase of 8.19%.
Cachet Pharmaceutical (002462.SZ) announced its interim report for the first half of 2024, with a reported revenue of 12.839 billion yuan, a year-on-year decrease of 13.70%; net income attributable to the shareholders of the listed company was 0.168 billion yuan, a year-on-year increase of 8.19%; net income attributable to the shareholders of the listed company after deducting non-recurring gains and losses was 0.107 billion yuan, a year-on-year decrease of 28.38%; basic earnings per share were 0.58 yuan.
No Data